113 related articles for article (PubMed ID: 27070693)
21. A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma.
Shou Y; Robinson DM; Amakye DD; Rose KL; Cho YJ; Ligon KL; Sharp T; Haider AS; Bandaru R; Ando Y; Geoerger B; Doz F; Ashley DM; Hargrave DR; Casanova M; Tawbi HA; Rodon J; Thomas AL; Mita AC; MacDonald TJ; Kieran MW
Clin Cancer Res; 2015 Feb; 21(3):585-93. PubMed ID: 25473003
[TBL] [Abstract][Full Text] [Related]
22. Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis.
Xu T; Zhang H; Park SS; Venneti S; Kuick R; Ha K; Michael LE; Santi M; Uchida C; Uchida T; Srinivasan A; Olson JM; Dlugosz AA; Camelo-Piragua S; Rual JF
Neoplasia; 2017 Mar; 19(3):216-225. PubMed ID: 28167297
[TBL] [Abstract][Full Text] [Related]
23. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression.
Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V
Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842
[TBL] [Abstract][Full Text] [Related]
24. Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics.
Romer J; Curran T
Cancer Res; 2005 Jun; 65(12):4975-8. PubMed ID: 15958535
[TBL] [Abstract][Full Text] [Related]
25. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.
Baryawno N; Sveinbjörnsson B; Eksborg S; Chen CS; Kogner P; Johnsen JI
Cancer Res; 2010 Jan; 70(1):266-76. PubMed ID: 20028853
[TBL] [Abstract][Full Text] [Related]
26. AT-101 inhibits hedgehog pathway activity and cancer growth.
Wang J; Peng Y; Liu Y; Yang J; Huang M; Tan W
Cancer Chemother Pharmacol; 2015 Sep; 76(3):461-9. PubMed ID: 26113054
[TBL] [Abstract][Full Text] [Related]
27. Blood Brain Barrier Phenotype Is Determined by Medulloblastoma Subtype.
Cancer Discov; 2016 Jun; 6(6):OF16. PubMed ID: 27080336
[TBL] [Abstract][Full Text] [Related]
28. Perspectives: Chemotherapy of medulloblastoma.
Mastrangelo S; Tornesello A; Mastrangelo R
Med Pediatr Oncol; 1999 Aug; 33(2):116-9. PubMed ID: 10398188
[No Abstract] [Full Text] [Related]
29. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
Dey A; Robitaille M; Remke M; Maier C; Malhotra A; Gregorieff A; Wrana JL; Taylor MD; Angers S; Kenney AM
Oncogene; 2016 Aug; 35(32):4256-68. PubMed ID: 26725322
[TBL] [Abstract][Full Text] [Related]
30. GDC-0449-a potent inhibitor of the hedgehog pathway.
Robarge KD; Brunton SA; Castanedo GM; Cui Y; Dina MS; Goldsmith R; Gould SE; Guichert O; Gunzner JL; Halladay J; Jia W; Khojasteh C; Koehler MF; Kotkow K; La H; Lalonde RL; Lau K; Lee L; Marshall D; Marsters JC; Murray LJ; Qian C; Rubin LL; Salphati L; Stanley MS; Stibbard JH; Sutherlin DP; Ubhayaker S; Wang S; Wong S; Xie M
Bioorg Med Chem Lett; 2009 Oct; 19(19):5576-81. PubMed ID: 19716296
[TBL] [Abstract][Full Text] [Related]
31. Restore the brake on tumor progression.
Gordon RE; Zhang L; Yang ZJ
Biochem Pharmacol; 2017 Aug; 138():1-6. PubMed ID: 28389227
[TBL] [Abstract][Full Text] [Related]
32. Hitting the target in medulloblastoma therapy.
Bradbury J
Drug Discov Today; 2004 Dec; 9(23):994-5. PubMed ID: 15574311
[No Abstract] [Full Text] [Related]
33. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
34. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.
Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167
[TBL] [Abstract][Full Text] [Related]
35. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
Liu L; Wan W; Xia S; Kalionis B; Li Y
Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
[TBL] [Abstract][Full Text] [Related]
36. Medulloblastoma: experimental models and reality.
Neumann JE; Swartling FJ; Schüller U
Acta Neuropathol; 2017 Nov; 134(5):679-689. PubMed ID: 28725965
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
von Bueren AO; Kortmann RD; von Hoff K; Friedrich C; Mynarek M; Müller K; Goschzik T; Zur Mühlen A; Gerber N; Warmuth-Metz M; Soerensen N; Deinlein F; Benesch M; Zwiener I; Kwiecien R; Faldum A; Bode U; Fleischhack G; Hovestadt V; Kool M; Jones D; Northcott P; Kuehl J; Pfister S; Pietsch T; Rutkowski S
J Clin Oncol; 2016 Dec; 34(34):4151-4160. PubMed ID: 27863192
[TBL] [Abstract][Full Text] [Related]
38. Patient-derived orthotopic xenograft models of medulloblastoma lack a functional blood-brain barrier.
Genovesi LA; Puttick S; Millar A; Kojic M; Ji P; Lagendijk AK; Brighi C; Bonder CS; Adolphe C; Wainwright BJ
Neuro Oncol; 2021 May; 23(5):732-742. PubMed ID: 33258962
[TBL] [Abstract][Full Text] [Related]
39. Hedgehog regulates cerebellar progenitor cell and medulloblastoma apoptosis.
Noguchi KK; Cabrera OH; Swiney BS; Salinas-Contreras P; Smith JK; Farber NB
Neurobiol Dis; 2015 Nov; 83():35-43. PubMed ID: 26319366
[TBL] [Abstract][Full Text] [Related]
40. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.
Hallahan AR; Pritchard JI; Hansen S; Benson M; Stoeck J; Hatton BA; Russell TL; Ellenbogen RG; Bernstein ID; Beachy PA; Olson JM
Cancer Res; 2004 Nov; 64(21):7794-800. PubMed ID: 15520185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
